Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma

Pedro, N. Y. H., López, E. R., Félix, G. V., Pineda, B., & Sotelo, J. (2013). An Update in the Use of Antibodies to Treat Glioblastoma Multiforme. Autoimmune Diseases, 2013(), 144-157. https://doi.org/10.1155/2013/716813
Gillam, A. W., Siegel, E., Mayes, D. A., Hutchins, L. F., & Zhou, Y. H. (2007). Anti-Tumor Effect of Doxycycline on Glioblastoma Cells. Journal of Cancer Molecules, 3(5), 147-153. https://doi.org/10.29685/JCM.200710.0003
Chamberlain, M. C. (2011). Bevacizumab for the Treatment of Recurrent Glioblastoma. Clinical Medicine Insights: Oncology, (), 117-129. https://doi.org/10.4137/CMO.S7232
Ohka, F., Natsume, A., & Wakabayashi, T. (2012). Current Trends in Targeted Therapies for Glioblastoma Multiforme. Neurology Research International, 2012(), 543-555. https://doi.org/10.1155/2012/878425
Zhuang, T. F. (2012). Adducin 3 and temozolomide resistance in glioblastoma multiforme [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200020170